The aim of the new addendum is introducing improved and more effective approaches to design development, clinical trials, monitoring of their progress, documentation and reporting, and standards for the maintenance of electronic documentation and mandatory...
On September 18-19 , the annual educational course of the cluster of biomedical research of the Skolkovo Foundation for the Development of Innovative Drugs was held. Representatives of start-ups, pharmaceutical companies and contract research organizations...
On September 14 IPHARMA celebrated the 5th anniversary of the work in the market of clinical trials in the loft on the territory of "Crystal". More than 100 guests, including researchers, partners and customers congratulated IPHARMA. The holiday...
On August 18th, 2017, IPHARMA was authorized by the Ministry of Healthcare of the Russian Federation to conduct the Phase IV clinical study of the medicinal product Alflutop®. Protocol № OA-ALF-01 «An open-label multicenter randomized clinical...
The webinar is dedicated to observation of the EEU Guideline "General considerations on clinical trials. EEU Guideline (based on ICH E8, ICH E1)". This guideline reveals general principles of the clinical study conduct, described in ICH E8, and provides...
On September 15 participation Ivaniuk N.M. in the debatable panel "The Medical Equipment and Products for Modern Traumatology and Orthopedics" which will pass within the second annual conference on biotechnologies – BIOTECHMED 2017 will take place...
In June 2017, the Eurasian Association for Quality Assurance started business. Experts of quality assurance system of clinical research have united to develop professional area, share experiences and create a community. ChemRar and IPHARMA have become...
On June 14 at 11:00 we will hold a webinar on the "Clinical trials in diabetes: approaches to drug development and methods for effectiveness and safety evaluating". Currently diabetology is one of the most actively developing branches of medical...
On June 2, ASCO Annual Meeting 2017, the main event of the year for specialists in the field of oncology, had started. Annually in Chicago, USA, more than 30,000 medical and pharmaceutical workers gather to discuss modern methods of treatment and innovative...
On May 30, 2017 IPHARMA received Ministry of Health permission to conduct a Phase I clinical trial of CD-008-0045. Protocol No. CD-008-0045 "A double-blind, randomized, placebo-controlled study of the safety, tolerability, and pharmacokinetics of increasing...
On May 22, 2017 IPHARMA received the Ministry of Health permission to conduct clinical trial of Phase I of the drug XC221. Protocol #ARI-XC221-01 "Double-blind randomized placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics...
On May, 24th at 11:00 am, we will hold a webinar on the “Introduction to monitoring: the role of Clinical Research Associate, beginning, responsibilities” . Clinical Research Associate plays the key role in clinical trial. The quality and success...
IPHARMA keeps leading positions among the contract research organizations in local clinical trials ( Research and information bulletin #14 Association of Clinical Trials Organization ACTO April, 6, 2017 ). In 2016 IPHARMA got 10 licences for conducting Phases...
On April 19th at 11:00 a.m. , we will hold the webinar on “GCP for Investigators. Quality assurance system organization in investigator sites” . Organization of quality system is important for the Sponsors and for the investigator sites. Quality...
On June 18-22nd IPHARMA will visit DIA 2017 Annual Meeting in Chicago, USA. IPHARMA will be presenting its business results for a third year running at the conference. We invite you to visit IPHARMA booth #847 to learn more of our company’s achievements...
On April, 12 IPHARMA took a part in XXIV Russian National Congress “Human and drug” . The congress is the partner of Pharma 2020 Programm and aimed to scientific experience and knowledges exchange. Authentic information expansion is the main...
Since March 27th to April 26th Skolkovo Biotechnology and Medical Cluster, Skolkovo Open University and fundamental medicine faculty hold the educational program “Pharma’s Cool 2017” . The program include innovative and technical experience...
On April 15th at 11:00 a.m. , we will hold the webinar on “GCP for Drug developers (Sponsors). Quality Assurance system organization” . Poorly conducted clinical trials mean the lack of them. Quality and safety is the foundation of the pharmaceutical...
On March 23 Julia Trakhtenberg, IPHARMA Medical Director, reported in VIII Scientific-Practical conference on the "Actual tasks of drugs safety evaluation" with the report "Data collection and safety evaluation planning. Clinical trials in diabetology"...
On March 29th IPHARMA requests the honor of Patient Communities, pharmaceutical companies, insurance companies and research organizations take part in Social and Pharmaceutical Forum in I.M. Sechenov First Moscow State Medical University (Research institute...
IPHARMA article "5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial)" has been published in the "Journal of Clinical...
On February, 15th at 11:00 a.m., we will hold a webinar on the "Findings during the inspections of Federal Service for Surveillance in Healthcare (Roszdravnadzor) in 2016" . Register to the webinar What will we discuss during the webinar? ...
IPHARMA participated as the expert in medicine and biotechnology sector GenerationS LifeScience choosing the strongest and the most successful start-ups and educational programs. The teams from Moscow, Moscow Region, Novosibirsk, Tomsk and Kazan competed...
Компания занимается разработкой и производством системы выравнивания зубов на основании 3D моделирования и 3D печати, а также владеет собственными Протоколами движения зубов в процессе лечения и программное обеспечение для 3D визуализации. Наша лаборатория...
On January, 25th at 11:00 am, we will hold a webinar on the “Project management on start-up of clinical trial”. Register to webinar What will we discuss during the webinar? • The specifics of project management on start-up stage...